Revenue segments as reported by the company.

Instruments & Accessories

Systems

Services

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Intuitive Surgical

Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Intuitive Surgical reports robust Q4 performance and eyes future growth

Intuitive Surgical's Q4 2022 showcased strong performance and growth in procedures and system placements.
While facing challenges like macroeconomic uncertainty and supply chain costs, the company is poised for continued innovation.
Opportunities lie in expanding markets, advancing technology, and improving surgical outcomes through collaboration.
Investments in industrial scale, automation, and platform advancements signal a strategic focus on future growth.

Intuitive Surgical (ISRG) reports robust Q1 performance and growth outlook

Intuitive Surgical (ISRG) delivered strong Q1 results with revenue up 14% and exceeding procedure growth expectations.
While facing challenges in manufacturing and supply chain, the company is focusing on R&D progress and inventory replenishment.
The outlook for 2023 looks promising with increased procedure growth forecasts and a focus on improving patient outcomes and market expansion.
Overall, Intuitive Surgical (ISRG) is well-positioned to capitalize on opportunities for growth and innovation in the robotic surgery market.

Intuitive Surgical excels in Q2 performance, eyes AI opportunities

Intuitive Surgical's Q2 2023 performance showcased strong revenue growth, procedure increases, and a focus on healthcare improvement.
The company's strengths include innovative ecosystem investments, commitment to patient outcomes, and advanced surgical technologies.
Challenges include market disruptions from new drugs, expense management, and adapting to changing healthcare landscapes.
Opportunities in AI, market expansion, and new procedures position Intuitive Surgical for continued growth and innovation.

Intuitive Surgical excels in Q3, eyes global expansion and margin growth

Intuitive Surgical's Q3 performance reflects strong growth and strategic focus on innovation and market expansion. Despite challenges in specific procedure categories and pricing dynamics, the company is well-positioned to capitalize on opportunities for growth and margin improvement.

Intuitive Surgical posts strong 2023 results, da Vinci 5 launch ahead

Intuitive Surgical's 2023 performance reflects strong revenue growth, operational excellence, and a strategic focus on innovation with the upcoming da Vinci 5 launch.
While facing challenges in operating margin pressure and supply chain issues, the company is well-positioned to capitalize on opportunities in soft tissue surgery, big data integration, and leased placements.
Investors should monitor how Intuitive Surgical navigates the launch of da Vinci 5, manages operational challenges, and leverages growth opportunities to sustain its market leadership.
Overall, Intuitive Surgical's Q4 earnings call highlights a resilient business model, customer-centric approach, and a commitment to advancing surgical technology for better patient outcomes.

Intuitive Surgical posts robust Q1 results amidst global market challenges

Intuitive Surgical delivered strong Q1 results with notable procedure and revenue growth, despite challenges in certain markets.
The company's focus on newer platforms, operational efficiency, and strategic outlook for 2024 positions it for continued success.
Addressing challenges and seizing opportunities in global markets and product innovation will be key for sustained growth and competitiveness.

Intuitive Surgical excels in Q2, eyes global expansion and innovation

Intuitive Surgical's Q2 performance reflects strength in procedure growth and system platform advancements.
The company's commitment to innovation and value creation positions them well for future success.
Challenges include sustaining margins and navigating market dynamics, while opportunities lie in expansion and innovation.
Overall, Intuitive Surgical's focus on growth, technology, and patient care sets a positive trajectory for the future.

Intuitive Surgical excels in Q3 with strong growth and innovation

Intuitive Surgical's Q3 2024 performance reflects a company in a strong position with notable achievements in procedures, financials, and technological advancements. While facing challenges in margin progression and international expansion, the company is well-positioned to leverage opportunities in innovation and customer insights.

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Fastenal

Infosys

There are plenty of large-cap stocks on the market which may look impressive based on their track records, but which have pretty much already finished growing, whether it be because they have already reached market saturation or because competition has disrupted the game. As a company grows, it becomes more and more difficult to achieve the kind of growth that impresses investors and leads to high valuation ratios.

3 High-Quality Stalwarts With Stellar GF Scores

Asure Software

DexCom

First Solar

Fastly

iShares U.S. Medical Devices ETF

Samsara

iShares Russell 2000 ETF

SPDR S&P Regional Banking ETF

NVIDIA

Invesco QQQ

Invesco Solar ETF

Markets have been known to have periods of "nasty" industry group rotation. Get ahead of the curve with these 3 under-the-radar groups.

Riding the Wave: These 3 Industry Groups are Making a Splash with Expected Money Inflows

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis.

Intuitive Surgical Continues to Surge, is it Worth Its Premium?

The Q1 results from Intuitive Surgical (NASDAQ: ISRG) confirm a trend that Marketbeat.com contributor Kate Stalter has been tracking this year. The results prove that innovation and the post-COVID environment combine to drive healthy results for med-tech companies.

Intuitive Surgical Carves A Bottom And Preps For Higher Prices

Micron Technology

ChatGPT may have drummed up the market's excitement for artificial intelligence stocks, but the AI industry itself is much broader than chat bots and large language models. It also includes technologies like intelligent automation, machine learning, self-driving cars, machine vision and more.

3 Predictable Stocks With Strong AI Tailwinds

Intuitive Surgical's (ISRG) first-quarter results reflect healthy demand for procedures, partially offset by unfavorable currency. COVID-19 impacts procedure volume in China.

Intuitive Surgical (ISRG) Gains Following Q1 Earnings Beat

Intuitive Surgical (NASDAQ:ISRG) Inc stock soared after the company posted first quarter results that beat Wall Street estimates handily, signaling a massive resurgence in the number of robotic surgical procedures. For the period ended March 31, 2023, the Sunnyvale, California-based pioneer of robotic surgery, reported earnings of $1.23 per share, beating consensus earnings estimate of $1.20 per share.

Intuitive Surgical stock pops after 1Q beat shows surgical robots reign

The robotic surgical systems leader beat Wall Street revenue and earnings estimates in Q1. Intuitive's solid performance came despite COVID-19 disruptions in China and foreign exchange headwinds.

Why Intuitive Surgical Stock Is Soaring Today

Although the revenue and EPS for Intuitive Surgical, Inc. (ISRG) give a sense of how its business performed in the quarter ended March 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Intuitive Surgical, Inc. (ISRG) Reports Q1 Earnings: What Key Metrics Have to Say

Intuitive Surgical, Inc. (ISRG) Q1 2023 Earnings Call Transcript

Intuitive Surgical, Inc. (ISRG) came out with quarterly earnings of $1.23 per share, beating the Zacks Consensus Estimate of $1.19 per share. This compares to earnings of $1.13 per share a year ago.

Intuitive Surgical, Inc. (ISRG) Surpasses Q1 Earnings and Revenue Estimates

Western Alliance Bancorporation

Markets were little changed on Tuesday. Intuitive Surgical stock surged after it posted a big rise in procedure volumes.

Netflix Reports, But Investors Are Happier About These 2 Other Stocks

Intuitive Surgical Inc beat estimates for first-quarter sales on Tuesday as the surgical robot maker recorded a rise in total procedure volumes.

Intuitive Surgical beats first-quarter sales on higher procedure volumes

Intuitive Surgical Inc. ISRG, +0.15% shares surged Tuesday after the surgical robotics company's quarterly results topped Wall Street estimates. Intuitive Surgical shares rose more than 9% after hours, following a 0.2% rise to close the regular session at $269.28.

Intuitive Surgical stock rallies after earnings beat

Intuitive Surgical said the number of procedures performed using its da Vinci system grew 26% in the first quarter. ISRG stock surged.

Robotic Surgery Giant Intuitive Surgical Rockets On Massive Procedure Growth

Franco-Nevada C

Monster Beverage

Globus Medical

Monolithic Power Systems

Power Integrations

Encore Wire

With a recession possibly on the horizon, investors may want to consider acquiring stocks with strong balance sheets. Of course, the underlying topic features much debate.

7 Stocks to Buy with Bulletproof Balance Sheets

Thermo Fisher Scientific

Investors interested in stocks from the Medical - Instruments sector have probably already heard of Thermo Fisher Scientific (TMO) and Intuitive Surgical, Inc. (ISRG). But which of these two stocks presents investors with the better value opportunity right now?

TMO vs. ISRG: Which Stock Is the Better Value Option?

Netflix

Tesla

Netflix stock is in a good technical setup ahead of its Q1 earnings report. Tesla and Intuitive Surgical are also on the earnings calendar.

Netflix Stock Shows Strength Ahead Of Q1 Results; Intuitive Surgical, Tesla Highlight Earnings Calendar

Axsome Therapeutics

Moderna

Here we discuss three medical stocks - AXSM, MRNA and ISRG - that have the potential to create wealth for investors over the coming years.

3 Medical Stocks With Solid Growth Potential to Keep Track Of

Intuitive Surgical's (ISRG) first-quarter results likely to reflect solid performance in the Instruments & Accessories segment. However, rising costs may have hurt margins.

Intuitive Surgical (ISRG) to Post Q1 Earnings: What's in Store?

We expect Intuitive Surgical to report revenue and earnings slightly above the street estimates, driven by a rise in total procedures volume.

Intuitive Surgical Stock To See Higher Levels Post Q1?

AbCellera Biologics

Alphabet

Alphabet has multiple ways to profit from greater use of AI in the healthcare sector. Intuitive Surgical is working on using AI to improve robotic surgery.

1 Sector Received $6.1 Billion in AI Investments Last Year: 3 Top Stocks to Buy

Warren Buffett (Trades, Portfolio) once said, “Price is what you pay, value is what you get.” This statement is especially true in regard to Intuitive Surgical Inc. ( ISRG , Financial).

Intuitive Surgical's Valuation Is Excessive

Intuitive Surgical is the market leader for minimally invasive robotic-assisted surgery. The stock has retained a very high valuation even through the stock market troubles of 2022.

Is Intuitive Surgical An Intuitive Buy?

Pfizer

Certain companies can bring you growth even through difficult economic times. They're often healthcare players.

News for Intuitive Surgical Stock (ISRG)